Literature DB >> 27959735

Perioperative Ledipasvir-Sofosbuvir for HCV in Liver-Transplant Recipients.

Josh Levitsky1, Elizabeth C Verna2, Jacqueline G O'Leary3, Natalie H Bzowej4, Dilip K Moonka5, Robert H Hyland6, Sarah Arterburn6, Hadas Dvory-Sobol6, Diana M Brainard6, John G McHutchison6, Norah A Terrault7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27959735     DOI： 10.1056/NEJMc1611829

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

Review 1.  Management of Advanced Fibrosis in the Context of Hepatitis C Virus Infection.

Authors:  Elizabeth C Verna
Journal:  Top Antivir Med       Date:  2017 Feb/Mar

2.  Use of a hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA-negative liver transplant recipient.

Authors:  Isabel Campos-Varela; Eliana Z Agudelo; Monika Sarkar; John P Roberts; Norah A Terrault
Journal:  Transpl Infect Dis       Date:  2018-01-03       Impact factor: 2.228

3.  Expanding the donor pool for lung transplantation using HCV-positive donors.

Authors:  Hrishikesh S Kulkarni; Kevin M Korenblat; Daniel Kreisel
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

4.  Transplanting hepatitis C virus-positive livers into hepatitis C virus-negative patients with preemptive antiviral treatment: A modeling study.

Authors:  Jagpreet Chhatwal; Sumeyye Samur; Emily D Bethea; Turgay Ayer; Fasiha Kanwal; Chin Hur; Mark S Roberts; Norah Terrault; Raymond T Chung
Journal:  Hepatology       Date:  2018-04-19       Impact factor: 17.425

5.  Center-level trends in utilization of HCV-exposed donors for HCV-uninfected kidney and liver transplant recipients in the United States.

Authors:  Mary G Bowring; Ashton A Shaffer; Allan B Massie; Andrew Cameron; Niraj Desai; Mark Sulkowski; Jacqueline Garonzik-Wang; Dorry L Segev
Journal:  Am J Transplant       Date:  2019-04-09       Impact factor: 8.086

6.  Hepatitis C Virus Treatment and Solid Organ Transplantation.

Authors:  Ronit Patnaik; Eugenia Tsai
Journal:  Gastroenterol Hepatol (N Y)       Date:  2022-02

7.  Changes in practice and perception of hepatitis C and liver transplantation: Results of a national survey.

Authors:  Ashton A Shaffer; Alvin G Thomas; Mary Grace Bowring; Sarah E Van Pilsum Rasmussen; Ayla Cash; Lauren M Kucirka; Saleh A Alqahtani; Ahmet Gurakar; Mark S Sulkowski; Andrew M Cameron; Dorry L Segev; Christine M Durand
Journal:  Transpl Infect Dis       Date:  2018-09-21       Impact factor: 2.228

8.  Discovery and Validation of a Biomarker Model (PRESERVE) Predictive of Renal Outcomes After Liver Transplantation.

Authors:  Josh Levitsky; Sumeet K Asrani; Goran Klintmalm; Thomas Schiano; Adyr Moss; Kenneth Chavin; Charles Miller; Kexin Guo; Lihui Zhao; Linda W Jennings; Merideth Brown; Brian Armstrong; Michael Abecassis
Journal:  Hepatology       Date:  2020-01-28       Impact factor: 17.425

9.  Hepatitis B and C virus infections transmitted through organ transplantation investigated by CDC, United States, 2014-2017.

Authors:  Danae Bixler; Pallavi Annambholta; Winston E Abara; Melissa G Collier; Jefferson Jones; Tonya Mixson-Hayden; Sridhar V Basavaraju; Sumathi Ramachandran; Saleem Kamili; Anne Moorman
Journal:  Am J Transplant       Date:  2019-04-29       Impact factor: 9.369

10.  Daclatasvir and sofosbuvir treatment of decompensated liver disease or post-liver transplant hepatitis C virus recurrence in patients with advanced liver disease/cirrhosis in a real-world cohort.

Authors:  Paul Kwo; Michael W Fried; K Rajender Reddy; Consuelo Soldevila-Pico; Saro Khemichian; Jama Darling; Phillippe J Zamor; Andrew A Napoli; Beatrice Anduze-Faris; Robert S Brown
Journal:  Hepatol Commun       Date:  2018-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.